(Bloomberg) -- Cadila Healthcare Ltd., an Indian drugmaker working to develop an indigenous coronavirus vaccine, said it expects to supply between 100 million to 150 million doses of its candidate this year.
The Ahmedabad-based firm’s ZyCoV-D vaccine was approved to commence with final stage human trials in December, and it is recruiting 30,000 volunteers for its phase 3 tests, according to a presentation filed with India’s stock exchanges on Tuesday. Cadila’s plasmid DNA candidate doesn’t use an infectious agent, like other vaccines, and instead introduces the DNA sequence encoding the antigen.
India is preparing to launch its coronavirus inoculation campaign on Jan. 16 with the aim of stemming the spread of the disease that has already infected more than 10 million people in the country. India’s drug regulator granted emergency approval for two vaccines shortly after new year’s day -- one from AstraZeneca Plc as well as a locally-developed one from Bharat Biotech International Ltd. -- despite a lack of final test efficacy data from the latter, which has prompted widespread criticism from scientists and public health experts.
Últimas Noticias
Debanhi Escobar: they secured the motel where she was found lifeless in a cistern
Members of the Specialized Prosecutor's Office in Nuevo León secured the Nueva Castilla Motel as part of the investigations into the case
The oldest person in the world died at the age of 119
Kane Tanaka lived in Japan. She was born six months earlier than George Orwell, the same year that the Wright brothers first flew, and Marie Curie became the first woman to win a Nobel Prize
Macabre find in CDMX: they left a body bagged and tied in a taxi
The body was left in the back seats of the car. It was covered with black bags and tied with industrial tape
The eagles of America will face Manchester City in a duel of legends. Here are the details
The top Mexican football champion will play a match with Pep Guardiola's squad in the Lone Star Cup
Why is it good to bring dogs out to know the world when they are puppies
A so-called protection against the spread of diseases threatens the integral development of dogs
